Literature DB >> 1831832

Developmental expression of CD45 alternate exons in murine T cells. Evidence of additional alternate exon use.

H L Chang1, L Lefrancois, M H Zaroukian, W J Esselman.   

Abstract

The CD45 glycoprotein family exhibits cell line-age-associated structural heterogeneity arising in part from alternate 5' exon shuffling. Previous studies of exons involved in the final glycoprotein structure have provided evidence of alternate exon use for only three exons (Ex-4, 5 and 6). However, our prior data using reverse transcription-polymerase chain reaction (RT-PCR) suggested the presence of at least one additional CD45 alternate exon. By using RT-PCR, Southern blotting with exon-specific or exon splice junction-specific oligonucleotide probes and direct DNA sequencing of RT-PCR products, we demonstrated additional alternate use involving Ex-7. PCR analysis of stage I thymocytes (CD4-CD8-) revealed only faintly detectable bands for two isoforms: one lacking Ex-4, 5, 6 and 7 (a "minus-one" [Ex(-1)] isoform), and a smaller isoform preliminarily characterized as also lacking Ex-8. Stage II thymocytes (CD4+CD8+) prominently expressed both Ex(-1) and zero alternate exon (Ex(0] isoforms, with one exon (Ex(1] and two exon (Ex(2] isoforms also present. Among stage III thymocytes, both CD4+CD8- and CD4-CD8+ cells expressed only Ex(-1) and Ex(0) isoforms. CD45 alternate exon use in resting CD4+ and CD8+ lymph node T cells was divergent, with CD8+ cells additionally expressing an Ex(2) isoform. Among alloreactive T cell clones, band intensity for the Ex(1) isoform in CD4+ BC-3 cells was much less than for resting CD4+ T cells, while the CD8+ CTL clone 8.2.2 exhibited production of the higher alternate exon isoforms, Ex(2) and Ex(3). We conclude that at least four and possibly five alternate exons exist in the CD45 glycoprotein family, with a previously unrecognized isoform lacking Ex-4, 5, 6 and 7 prominently expressed in T cells. Shuffling of CD45 alternate exons appears to occur in an organized and predictable sequence during cellular maturation and activation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1831832

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  9 in total

1.  Genomic organization of the channel catfish CD45 functional gene and CD45 pseudogenes.

Authors:  Evgueni Kountikov; Melanie Wilson; Sylvie Quiniou; Norman Miller; William Clem; Eva Bengtén
Journal:  Immunogenetics       Date:  2005-05-03       Impact factor: 2.846

Review 2.  CD45: all is not yet crystal clear.

Authors:  Nick Holmes
Journal:  Immunology       Date:  2006-02       Impact factor: 7.397

Review 3.  Regulation of cell signaling by the protein tyrosine phosphatases, CD45 and SHP-1.

Authors:  T Ulyanova; J Blasioli; M L Thomas
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

4.  CD45 expression by murine B cells and T cells: alteration of CD45 isoforms in subpopulations of activated B cells.

Authors:  K S Hathcock; H Hirano; R J Hodes
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

5.  Genetic basis of antigenic differences between three alleles of Ly5 (CD45) in mice.

Authors:  W C Raschke; M Hendricks; C M Chen
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  The extracellular domain of CD45 controls association with the CD4-T cell receptor complex and the response to antigen-specific stimulation.

Authors:  D Leitenberg; T J Novak; D Farber; B R Smith; K Bottomly
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

7.  CD45RA and CD45RBhigh expression induced by thymic selection events.

Authors:  V A Wallace; W P Fung-Leung; E Timms; D Gray; K Kishihara; D Y Loh; J Penninger; T W Mak
Journal:  J Exp Med       Date:  1992-12-01       Impact factor: 14.307

8.  Altered T-cell function in schizophrenia: a cellular model to investigate molecular disease mechanisms.

Authors:  Rachel M Craddock; Helen E Lockstone; David A Rider; Matthew T Wayland; Laura J W Harris; Peter J McKenna; Sabine Bahn
Journal:  PLoS One       Date:  2007-08-01       Impact factor: 3.240

9.  Identification of amino acids at the junction of exons 3 and 7 that are used for the generation of glycosylation-related human CD45RO and CD45RO-like antigen specificities.

Authors:  R Pulido; S F Schlossman; H Saito; M Streuli
Journal:  J Exp Med       Date:  1994-03-01       Impact factor: 14.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.